
Zymeworks
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics.
Market cap
$1.1b
Enterprise value
$868m
Share price
$14.84 ZYME
Authorizing premium user...
Computational biotechnology company that is focused on optimizing therapeutic antibodies and other protein-based therapeutics.